nektar therapeutics (NKTR:NASDAQ GS)
Dean Hess Ph.D.
Member of Scientific Advisory Group, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 28 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dean Hess Ph.D., serves as Member of Scientific Advisory Group of Nektar Therapeutics. Dr. Hess serves as Assistant Professor of Anesthesia, Harvard Medical School, Massachusetts General Hospital. Dr. Hess is Expertise in Critical Care and Aerosol Delivery areas.
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$1.0M||Compensation as of Fiscal Year 2014.|